BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Nov 08, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Stool DNA colorectal cancer screening assay diagnostic data

Exact Sciences Corp. (NASDAQ:EXAS), Madison, Wis.
Product: Stool DNA colorectal cancer screening assay ( Cologuard)
Business: Diagnostic
Molecular target: NA
Description: Noninvasive stool DNA test that utilizes a multiplexed quantitative Invader assay for...

Read the full 157 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >